XGN Competitors & Alternatives
Compare Exagen Inc with similar stocks in the same industry
Diagnostics & Research
XGN
Main Stock$3.64
Tradestie Score
61
Market Cap
$241.60M
Revenue Growth
0.1%
Analyst Upside
+138.1%
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OPK
Opko Health Inc.
|
$1.10
|
$1.23B | - | 56 | Compare |
|
NEO
NeoGenomics, Inc.
|
$8.24
|
$1.13B | - | 54 | Compare |
|
CDNA
CareDx, Inc.
|
$19.97
|
$798.40M | - | 49 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$19.13
|
$667.77M | - | 52 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$6.36
|
$612.76M | - | 63 | Compare |
|
FULC
Fulcrum Therapeutics, Inc. Common Stock
|
$6.69
|
$504.67M | - | 54 | Compare |
|
APYX
Apyx Medical Corporation Common Stock
|
$4.05
|
$81.31M | - | 52 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$14.17
|
$61.36M | - | 52 | Compare |
|
TELA
TELA Bio, Inc. Common Stock
|
$0.91
|
$59.42M | - | 55 | Compare |
|
VRCA
Verrica Pharmaceuticals Inc. Common Stock
|
$6.27
|
$41.94M | - | 53 | Compare |
More XGN Analysis
Data updated: May 18, 2026 | Industry: Diagnostics & Research (SIC 8071)
38 stocks in this industry